‘Aripiprazole’ schizophrenia market opens by its PMS expiration

Published: 2015-11-16 10:16:22

Updated: 2015-11-16 10:16:22

The market of ‘aripiprazole’ drugs, schizophrenia treatments whose patent will be expired in PMS, will widely open on the coming 20^th.

According to the Ministry of Food and Drug Safety, the number of products which are approved as single medicine of aripiprazole, is 58 products and has continuously increased since 2010.

The market has been solidly firmed by the total 7 products of Otsuka Phar...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.